Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Neonatology

Understanding Congenital Chylothorax

At a Glance

Congenital chylothorax is a rare condition where lymph fluid (chyle) builds up around a newborn's lungs, causing breathing difficulty. Caused by abnormal lymphatic development, treatment in the NICU involves fluid drainage, specialized MCT diets, medications, and sometimes surgery.

Finding out your newborn has a rare condition like congenital chylothorax (a buildup of lymph fluid around the lungs) can be overwhelming. It is natural to feel a profound sense of “NICU whiplash”—the shock of moving from the expectation of a healthy birth to the complex reality of intensive care. Please know that your fear and anxiety are valid; you are navigating a situation that few parents ever have to face.

What is Congenital Chylothorax?

Congenital chylothorax occurs when chyle (a milky-white fluid rich in fats and immune cells) leaks into the pleural space, which is the thin area between the lungs and the chest wall [1][2]. While it is a rare diagnosis, it is recognized as the most common cause of pleural effusions (fluid around the lungs) in the neonatal period [3][4].

The Biological Mechanism: Lymphatic Dysplasia

The primary cause of this fluid buildup is typically lymphatic dysplasia. In simple terms, this means the lymphatic system—the network of vessels that drains fluid from tissues and transports fats—did not develop normally [1][5].

This “mis-wiring” can happen in a few ways:

  • Hypoplasia: The lymphatic vessels are too few or too small to carry the fluid load [6].
  • Hyperplasia: The vessels are overgrown or misdirected, causing fluid to leak or flow backward into the chest [5][7].
  • Structural Defects: There may be a specific “break” or leak in the thoracic duct, the main “highway” of the lymphatic system [8].

Why the Fluid Matters

When chyle accumulates in the space around the lungs, it acts like a physical barrier. Because the chest is a rigid “box,” the fluid takes up space that the lungs need to expand. This compression prevents the lungs from filling with air, leading to respiratory distress (difficulty breathing) [9][3].

Furthermore, chyle is rich in immune cells called lymphocytes. Repeatedly draining this fluid can deplete your baby’s immune reserves, putting them at a higher risk for infection [10]. This is why the NICU staff will be exceptionally strict about handwashing, hygiene, and monitoring for signs of illness.

Current Landscape of Care

Because every baby’s lymphatic anatomy is unique, there is no “one-size-fits-all” treatment plan. Research confirms that there is currently no global standardized protocol for treating this condition [11][8].

Instead, the medical community agrees on a multidisciplinary approach [8][12]. This means your baby’s care will likely involve a team of specialists, including:

  • Neonatologists: Doctors who specialize in newborn intensive care.
  • Pediatric Pulmonologists: Lung specialists.
  • Pediatric Surgeons: To manage chest tubes or surgical repairs if needed.
  • Registered Dietitians: To manage specialized formulas that reduce the “workload” on the lymphatic system [13].

Management Strategies

Treatment usually follows a “stepwise” path, starting with the least invasive options:

  1. Drainage: Using a needle (thoracocentesis) or a chest tube to remove the fluid and allow the lungs to expand [8][13].
  2. Dietary Changes: Using specialized formulas high in medium-chain triglycerides (MCT). These fats are absorbed directly into the blood rather than the lymph, which helps “rest” the leaky vessels [13].
  3. Medications: Drugs like octreotide may be used to reduce the overall production of lymph fluid [14][15].
  4. Advanced Imaging and Surgery: In persistent cases, doctors may use specialized scans (like lymphangiography) to find the leak and repair it surgically [16][17].

While the path forward can feel uncertain, focus on the “stabilizing facts”: your team is working to manage the fluid, support your baby’s breathing, and identify the underlying cause through a collaborative, expert-led process.

Common questions in this guide

What causes congenital chylothorax?
It is typically caused by lymphatic dysplasia, a condition where the baby's lymphatic system does not develop properly. This can include vessels that are too small, overgrown, or have structural defects that leak fluid into the chest cavity.
Why does congenital chylothorax make breathing difficult?
The fluid accumulates in the rigid space of the chest, creating a physical barrier. This fluid compresses the lungs and prevents them from fully expanding with air, which leads to respiratory distress.
Why is my baby given a special MCT diet in the NICU?
Babies with this condition are often fed formulas high in medium-chain triglycerides (MCT). These specific fats are absorbed directly into the blood rather than the lymph system, which helps reduce the amount of fluid passing through the leaky vessels.
Why is my baby at a higher risk for infection?
Chyle fluid is very rich in immune cells called lymphocytes. Because treatment requires repeatedly draining this fluid, your baby can lose these important immune reserves, making them highly vulnerable to infections.
What are the treatment options for congenital chylothorax?
Treatment usually begins with draining the fluid using a needle or chest tube to help the lungs expand. The care team may also use specialized dietary formulas, medications to slow fluid production, or surgery if the leak is persistent.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on our baby's imaging, do you suspect a structural issue like a thoracic duct tear or a more generalized condition like lymphatic dysplasia?
  2. 2.Is our baby's chylothorax associated with any other findings, such as hydrops fetalis or a specific genetic syndrome?
  3. 3.What is the daily volume of fluid being drained, and at what point would we consider moving from dietary changes to medications or surgery?
  4. 4.What are the specific criteria or milestones you use to determine if the current treatment is successful?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Causes and manifestations of chylothorax in children.

    Bellini C, De Angelis LC, Bellini T, Ramenghi LA

    Pediatric investigation 2018; (2(3)):203 doi:10.1002/ped4.12057.

    PMID: 32851263
  2. 2

    Chylothorax: A Stepwise Approach to Diagnosis and Treatment.

    Jackson S, Jnah AJ

    Neonatal network : NN 2021; (40(6)):386-392 doi:10.1891/11-T-705.

    PMID: 34845089
  3. 3

    Clinical features and outcomes of congenital chylothorax: a single tertiary medical center experience in China.

    Wang B, Feng Y, Guo Y, et al.

    Journal of cardiothoracic surgery 2022; (17(1)):276 doi:10.1186/s13019-022-02009-z.

    PMID: 36303149
  4. 4

    Causes and manifestations of chylothorax in children in China: Experience from a children's medical center, 2007-2017.

    Guo Y, Chen J, Xu B, et al.

    Pediatric investigation 2018; (2(1)):8-14 doi:10.1002/ped4.12019.

    PMID: 32851223
  5. 5

    An Updated Classification of Primary Lymphedema Based on Age of Onset, Lymphatic Anomalies, and Genetics.

    Liu NF, Gao MZ, Maltese PE, Bertelli M

    Lymphology 2023; (56(3)):99-109.

    PMID: 38896493
  6. 6

    Utility of contrast-enhanced magnetic resonance lymphangiography for yellow nail syndrome with lymphangiopathy: a case report.

    Shimanuki Y, Miyoshi S, Anzai N, et al.

    Oxford medical case reports 2022; (2022(7)):omac077 doi:10.1093/omcr/omac077.

    PMID: 35903624
  7. 7

    PIEZO1 variant implications for biological understanding and human health.

    Cheng CW, Earle SL, Povstyan OV, et al.

    Open biology 2025; (15(7)):240345 doi:10.1098/rsob.240345.

    PMID: 40628291
  8. 8

    Neonatal Lymphatic Flow Disorder.

    Toptan HH, Ozalkaya E, Karadag N, et al.

    Indian journal of pediatrics 2024; (91(3)):248-253 doi:10.1007/s12098-023-04531-x.

    PMID: 37040015
  9. 9

    Non-immune hydrops fetalis secondary to congenital chylothorax with diffuse interstitial lung disease: a diagnostic conundrum.

    Ngeow AJH, Chan MY, Teoh OH, et al.

    BMJ case reports 2021; (14(4)) doi:10.1136/bcr-2020-240688.

    PMID: 33863770
  10. 10

    Milky pleural effusion in a neonate and approach to investigating chylothorax.

    Senarathne UD, Rodrigo R, Dayanath BKTP

    BMJ case reports 2021; (14(9)) doi:10.1136/bcr-2021-245576.

    PMID: 34588205
  11. 11

    Management and outcomes of congenital chylothorax in the neonatal intensive care unit: A case series.

    Healy H, Gipson K, Hay S, et al.

    Pediatric investigation 2017; (1(1)):21-25 doi:10.1002/ped4.12007.

    PMID: 32851213
  12. 12

    Congenital chylothorax: Current evidence-based prenatal and post-natal diagnosis and management.

    De Angelis LC, Bellini T, Witte MH, et al.

    Lymphology 2019; (52(3)):108-125.

    PMID: 31874123
  13. 13

    Multidisciplinary Management of Chylothorax.

    Agrawal A, Chaddha U, Kaul V, et al.

    Chest 2022; (162(6)):1402-1412 doi:10.1016/j.chest.2022.06.012.

    PMID: 35738344
  14. 14

    The use of high dose octreotide in management of neonatal chylothorax: Review.

    Alhasoon MA

    Journal of neonatal-perinatal medicine 2021; (14(4)):457-461 doi:10.3233/NPM-200644.

    PMID: 33843702
  15. 15

    Effects of somatostatin/octreotide treatment in neonates with congenital chylothorax.

    Yin R, Zhang R, Wang J, et al.

    Medicine 2017; (96(29)):e7594 doi:10.1097/MD.0000000000007594.

    PMID: 28723800
  16. 16

    Indocyanine green lymphography in the congenital chylothorax and chylous ascites.

    Lin T, Shibasaki J, Yamamoto K, et al.

    Journal of neonatal-perinatal medicine 2024; (17(2)):247-254 doi:10.3233/NPM-230171.

    PMID: 38640176
  17. 17

    Efficacy of Early Pleurectomy for Severe Congenital Chylothorax.

    Rubalcava NS, Perrone EE, Church JT, et al.

    The Journal of surgical research 2020; (256()):433-438 doi:10.1016/j.jss.2020.07.005.

    PMID: 32795706

This page provides educational information about congenital chylothorax to help parents understand the diagnosis. It is not a substitute for professional medical advice from your baby's neonatologist or NICU care team.

Get notified when new evidence is published on Congenital chylothorax.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.